Table 4.
Study withdrawal reason | n | % |
---|---|---|
Discontinuation of tofacitinib due to intolerance or adverse event | 2 | 13.3% |
Discontinuation of tofacitinib due to lack of efficacy | 4 | 26.7% |
Surgery (colectomy) | 5 | 33.3% |
Lack of patient’s cooperation with survey completion | 3 | 20.0% |
Patient’s request to withdraw from registry | 1 | 6.7% |